AstraZeneca considers merger with Bristol Myers Squibb
Story essentials
AstraZeneca, Bristol Myers Squibb
UK, USA
August 2, 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 18/2/2026, 10:50:35 PM
AstraZeneca is reportedly in talks to merge with US rival Bristol Myers Squibb. The combined market value of the two companies is approximately 400 billion dollars. A deal could create one of the world's largest pharmaceutical companies.
Read next
Prioritized by shared people, places, and events.
Federal judge denies xAI's motion to dismiss NAACP lawsuit over data center permits
A federal judge denied xAI's motion to dismiss a lawsuit filed by the NAACP. The lawsuit alleges that xAI operated gas turbines at its Colossus data center without required air permits. The court affirmed that the plaintiffs have standing to sue under the Clean Air Act.